Concepedia

DA Wohl

DW

3

Publications

63

Citations

3

H-Index

2010

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

DA Wohl is an author at University of North Carolina at Chapel Hill specializing in hiv, pharmacotherapy, and clinical trials.

Top concepts

HivMedicinePharmacologyClinical TrialsPharmacotherapy

Publications per year

2010–2015

3

Publications

3

STAR Study: single tablet regimen emtricitabine/rilpivirine/tenofovir DF is non‐inferior to efavirenz/emtricitabine/tenofovir DF in ART‐naïve adults

Cal Cohen, DA Wohl, José Ramón Arribas et al. · Journal of the International AIDS Society · 2012 · 29 citations · Full text

Superior Efficacy, Fda Snapshot Algorithm, Single Tablet Regimen +13

The <scp>ASSURE</scp> study: <scp>HIV</scp>‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir

DA Wohl, Laveeza Bhatti, CB Small et al. · HIV Medicine · 2015 · 19 citations · Full text

Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race

P Menezes, JJ Eron, PA Leone et al. · HIV Medicine · 2010 · 15 citations

Rows per page

1–3 of 3